Evidence map›Paper›PMID 40733140›Full record

ArticlePharmaceutics2025

Chitosan Microparticles Coupled with MAGE-AX and CpGs as a Treatment for Murine Melanoma.

Gabriela Piñón-Zárate, Beatriz Hernández-Téllez, Ariel Ramírez-Cortés, Katia Jarquín-Yáñez, Enrique A Sampedro-Carrillo, Miguel A Herrera-Enríquez, Christian A Cárdenas-Monroy, Andrés E Castell-Rodríguez

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gabriela Piñón-ZárateLaboratory of Immunotherapy and Tissue Engineering, Faculty of Medicine, National Autonomous University of Mexico, Mexico City 04510, Mexico.ORCID 0000-0002-3080-9703
Beatriz Hernández-TéllezLaboratory of Immunotherapy and Tissue Engineering, Faculty of Medicine, National Autonomous University of Mexico, Mexico City 04510, Mexico.
Ariel Ramírez-CortésLaboratory of Immunotherapy and Tissue Engineering, Faculty of Medicine, National Autonomous University of Mexico, Mexico City 04510, Mexico.
Katia Jarquín-YáñezLaboratory of Immunotherapy and Tissue Engineering, Faculty of Medicine, National Autonomous University of Mexico, Mexico City 04510, Mexico.
Enrique A Sampedro-CarrilloLaboratory of Immunotherapy and Tissue Engineering, Faculty of Medicine, National Autonomous University of Mexico, Mexico City 04510, Mexico.
Miguel A Herrera-EnríquezLaboratory of Immunotherapy and Tissue Engineering, Faculty of Medicine, National Autonomous University of Mexico, Mexico City 04510, Mexico.ORCID 0000-0003-3939-3254
Christian A Cárdenas-MonroyLaboratory of Genetics, National School of Forensic Sciences, National Autonomous University of Mexico, Mexico City 04510, Mexico.ORCID 0000-0002-3768-1618
Andrés E Castell-RodríguezLaboratory of Immunotherapy and Tissue Engineering, Faculty of Medicine, National Autonomous University of Mexico, Mexico City 04510, Mexico.ORCID 0000-0003-2881-2759

Funding

PAPIIT-DGAPA UNAM IN216723, IA203025 and IT200525
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomaterialschitosan microparticlesimmunotherapymelanoma

Identifiers

PMID40733140
PMCPMC12300736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.